Alcohol withdrawal syndrome

Advanced Emergency Nursing Journal

Volumn 32, Issue 1, 2010, Pages 20-27

  Lemon Jr , Stephen J ^a   Winstead, P Shane ^a   Weant, Kyle A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alcohol; Barbiturates; Benzodiazepines; Delirium tremens; Withdrawal

Indexed keywords

EID: 77249159957     PISSN: 19314485     EISSN: None     Source Type: Journal    
DOI: 10.1097/TME.0b013e3181cae050     Document Type: Article

References (59)

1. Abraham, E., Shoemaker, W. C., & McCartney, S. F. (1985). Cardiorespiratory patterns in severe delirium tremens. Archives of Internal Medicine, 145, 1057-1059.
2. Adinoff, B. (1994). Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: Preliminary findings. Alcoholism, Clinical and Experimental Research, 18, 873-878.
3. Al-Sanouri, I., Dikin, M., & Soubani, A. O. (2005). Critical care aspects of alcohol abuse. Southern Medical Journal, 98, 372-381.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSMIV- TR. Washington, DC: Author.
5. Ballenger, J. C., & Post, R. M. (1978). Kindling as a model for alcohol withdrawal syndromes. British Journal of Psychiatry, 133, 1-14.
6. Becker, H. C. (1998). Kindling in alcohol withdrawal. Alcohol Health and Research World, 22(1), 25-33.
7. Bird, R. D., & Makela, E. H. (1994). Alcohol withdrawal: What is the benzodiazepine of choice? Annals of Pharmacotherapy, 28(1), 67-71.
8. Bjorkqvist, S. E. (1975). Clonidine in alcohol withdrawal. Acta Psychiatrica Scandinavica, 52, 256-263.
9. Bourgouin, P. M., Chalk, C., Richardson, J., Duang, H., & Vezina, J. L. (1995). Subcortical white matter lesions in osmotic demyelination syndrome. American Journal of Neuroradiology, 16, 1495-1497.
10. Brathen, G., Ben-Menachem, E., Brodtkorb, E., Galvin, R., Garcia-Monco, J. C., Halasz, P., . . . Young, A. B. (2005). EFNS guideline on the diagnosis and management of alcohol-related seizures: Report of an EFNS task force. European Journal of Neurology, 12, 575-581.
11. Cargiulo, T. (2007). Understanding the health impact of alcohol dependence. American Journal of Health- System Pharmacy, 64(5, Suppl. 3), S5-S11.
12. Daeppen, J. B., Gache, P., Landry, U., Sekera, E., Schweizer, V., Gloor, S., & Yersin B. (2002). Symptomtriggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: A randomized treatment trial. Archives of Internal Medicine, 162, 1117-1121.
13. DeBellis, R., Smith, B. S., Choi, S., & Malloy, M. (2005). Management of delirium tremens. Journal of Intensive Care Medicine, 20(3), 164-173.
14. Devetag, F., Mandich, G., Zaiotti, G., & Toffolo, G. G. (1983). Alcoholic epilepsy: Review of a series and proposed classification and etiopathogenesis. Italian Journal of Neurological Sciences, 4, 275-284.
15. Etherington, J. M. (1996). Emergency management of acute alcohol problems, 1: Uncomplicated withdrawal. Canadian Family Physician, 42, 2186-2190.
16. Ewing, J. A. (1984). Detecting alcoholism. The CAGE questionnaire. JAMA, 252, 1905-1907.
17. Ferguson, J. A., Suelzer, C. J., Eckert, G. J., Zhou, X. H., & Dittus, R. S. (1996). Risk factors for delirium tremens development. Journal of General Internal Medicine, 11, 410-414.
18. Griffiths, R. R., & Wolf, B. (1990). Relative abuse liability of different benzodiazepines in drug abusers. Journal of Clinical Psychopharmacology, 10, 237-243.
19. Hardern, R., & Page, A. V. (2005). An audit of symptom triggered chlordiazepoxide treatment of alcohol withdrawal on a medical admissions unit. Emergency Medicine Journal, 22(11), 805-806.
20. Hassaballa, H. A., & Balk, R. A. (2003). Torsade de pointes associated with the administration of intravenous haloperidol: A review of the literature and practical guidelines for use. Expert Opinion on Drug Safety, 2, 543-547.
21. Hayner, C. E., Wuestefeld, N. L., & Bolton, P. J. (2009). Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome. Pharmacotherapy, 29, 875-878.
22. Heinz, A., Schmidt, K., Baum, S. S., Kuhn, S., Dufeu, P., Schmidt, L. G., Rommelspacher, H. (1996). Influence of dopaminergic transmission on severity of withdrawal syndrome in alcoholism. Journal of Studies on Alcohol and Drugs, 57, 471-474.
23. Hillbom, M., Pieninkeroinen, I., & Leone, M. (2003). Seizures in alcohol-dependent patients: Epidemiology, pathophysiology and management. CNS Drugs, 17, 1013-1030.
24. Hobbs, W., Rall, T., & Verdoorn, T. (1996). Hypnotics and sedatives: Ethanol. In J. Hardman & L. Limbird (Eds.), Goodman & Gilman's the pharmacological basis of therapeutics (9th ed., pp. 361-396). New York, NY: McGraw-Hill.
25. Hughes, J. R. (2009). Alcohol withdrawal seizures. Epilepsy & Behavior, 15(2), 92-97.
26. Jaeger, T. M., Lohr, R. H., & Pankratz, V. S. (2001). Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clinic Proceedings, 76, 695-701.
27. Kahkonen, S. (2006). Responses to cardiovascular drugs during alcohol withdrawal. Alcohol, 41(1), 11-13.
28. Kosten, T. R., & O'Connor, P. G. (2003). Management of drug and alcohol withdrawal. New England Journal of Medicine, 348, 1786-1795.
29. Kraus, M. L., Gottlieb, L. D., Horwitz, R. I., & Anscher, M. (1985). Randomized clinical trial of atenolol in patients with alcohol withdrawal. New England Journal of Medicine, 313, 905-909.
30. Laureno, R., & Karp, B. I. (1997). Myelinolysis after correction of hyponatremia. Annals of Internal Medicine, 126, 57-62.
31. Lejoyeux, M., Solomon, J., & Ades, J. (1998). Benzodiazepine treatment for alcohol-dependent patients. Alcohol, 33(6), 563-575.
32. Lien, Y. H. (1995). Role of organic osmolytes inmyelinolysis. A topographic study in rats after rapid correction of hyponatremia. Journal of Clinical Investigation, 95, 1579-1586.
33. Lum, E., Gorman, S. K., & Slavik, R. S. (2006). Valproic acid management of acute alcohol withdrawal. Annals of Pharmacotherapy, 40, 441-448.
34. Malcolm, R., Ballenger, J. C., Sturgis, E. T., & Anton, R. (1989). Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. American Journal of Psychiatry, 146, 617-621.
35. Malcolm, R., Myrick, H., Roberts, J., Wang, W., Anton, R. F., & Ballenger, J. C. (2002). The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. Journal of General Internal Medicine, 17, 349-355.
36. Mayo-Smith, M. F. (1997). Pharmacological management of alcohol withdrawal. A meta-analysis and evidencebased practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA, 278, 144-151.
37. Mayo-Smith, M. F., & Bernard, D. (1995). Late-onset seizures in alcohol withdrawal. Alcoholism, Clinical and Experimental Research, 19, 656-659.
38. McKeon, A., Frye, M. A., & Delanty, N. (2008). The alcohol withdrawal syndrome. Journal of Neurology, Neurosurgery, and Psychiatry, 79, 854-862.
39. Miller, W. C., Jr., & McCurdy, L. (1984). A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome. Clinical Therapeutics, 6, 364-371.
40. Ntais, C., Pakos, E., Kyzas, P., & Ioannidis, J. P. (2005). Benzodiazepines for alcohol withdrawal. Cochrane Database Systematic Review, (3), CD005063.
41. Nutt, D. (1999). Alcohol and the brain. Pharmacological insights for psychiatrists. British Journal of Psychiatry, 175, 114-119.
42. Palestine, M. L., & Alatorre, E. (1976). Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide. Current Therapeutic Research, Clinical and Experimental, 20(3), 289-299.
43. Pearce, J. M. (2008). Wernicke-Korsakoff encephalopathy. European Journal of Neurology, 59(1/2), 101-104.
44. Reinert, D. F., & Allen, J. P. (2002). The Alcohol Use Disorders Identification Test (AUDIT): A review of recent research. Alcoholism, Clinical and Experimental Research, 26(2), 272-279.
45. Reynolds, R. M., Padfield, P. L., & Seckl, J. R. (2006). Disorders of sodium balance. BMJ, 332(7543), 702-705.
46. Saitz, R., Mayo-Smith, M. F., Roberts, M. S., Redmond, H. A., Bernard, D. R., & Calkins, D. R. (1994). Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA, 272, 519-523.
47. Sanna, E., Mostallino, M. C., Busonero, F., Talani, G., Tranquilli, S., Mameli, M., . . . Biggio G. (2003). Changes in GABA(A) receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. Journal of Neuroscience, 23, 11711-11724.
48. Schik, G.,Wedegaertner, F. R., Liersch, J., Hoy, L., Emrich, H. M., & Schneider, U. (2005). Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal. Addiction Biology, 10, 283-288.
49. Segatore, M., Adams, D., & Lange, S. (1999). Managing alcohol withdrawal in the acutely ill hospitalized adult. Journal of Neuroscience Nursing, 31(3), 129-141.
50. Sellers, E. M., Zilm, D. H., & Degani, N. C. (1977). Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. Journal of Studies on Alcohol and Drugs, 38, 2096-2108.
51. Stuppaeck, C. H., Pycha, R., Miller, C., Whitworth, A. B., Oberbauer, H., & Fleischhacker, W. W. (1992). Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: A double-blind study. Alcohol, 27, 153-158.
52. Sullivan, J. T., Sykora, K., Schneiderman, J., Naranjo, C. A., & Sellers, E. M. (1989). Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar). British Journal of Addiction, 84, 1353-1357.
53. Tetrault, J. M., & O'Connor, P. G. (2008). Substance abuse and withdrawal in the critical care setting. Critical Care Clinics, 24(4), 767-788, viii.
54. Tsai, G., & Coyle, J. T. (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annual Review of Medicine, 49, 173-184.
55. Tsai, G., Gastfriend, D. R., & Coyle, J. T. (1995). The glutamatergic basis of human alcoholism. American Journal of Psychiatry, 152, 332-340.
56. Substance Abuse and Mental Health Services Administration. (2009). Results from the 2008 National Survey on Drug Use and Health: National findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No: SMA 09-4434). Retrieved fromhttp:// oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.pdf.
57. Verma, N. P., Policherla, H., & Buber, B. A. (1992). Prior head injury accounts for the heterogeneity of the alcohol-epilepsy relationship. Clinical Electroencephalography, 23(3), 147-151.
58. Wax, P. (1996). Withdrawal syndrome. In J. Rippe, R. Irwin, M. Fink, et al. (Eds.), Intensive care medicine (3rd ed., pp. 1718-1726). Boston, MA: Little Brown and Company.
59. Williams, D., Lewis, J., & McBride, A. (2001). A comparison of rating scales for the alcohol-withdrawal syndrome. Alcohol, 36(2), 104-108.